Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma — Stella

Home/Advanced Intrahepatic Cholangiocarcinoma/HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

View on ClinicalTrials.gov

Recruiting

Back to Advanced Intrahepatic Cholangiocarcinoma trials

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Chinese PLA General Hospital, Beijing, Beijing Municipality

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Hutchmed

Enrollment target

~235 participants

Started

September 2020

Primary completion

June 2028

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.